copyright 2018 npr. to see more, visit /www.npr.org/.
.
.one woman's migraine story
.
.
.
.
.
. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
.
.
.
loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.